Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. genesis nutrition ultra slim
WARNING LETTER
•genesis nutrition ultra slim •September 7, 2021

genesis nutrition ultra slim – FDA Warning Letter, Sep 7, 2021

Record Details

The FDA issued a Warning Letter to Ms. Gonzalez regarding "Genesis Ultra Slim Gold," sold on www.fastweightlossgarcinia.com and www.ketoultraslimplus.com, and promoted via social media. An FDA lab analysis confirmed the product contains undeclared sibutramine and phenolphthalein.

Sibutramine, an active pharmaceutical ingredient in the withdrawn drug Meridia, was linked to increased risks of heart attack and stroke. Phenolphthalein is a chemical not approved as a drug ingredient and poses a cancer risk.

The FDA determined "Genesis Ultra Slim Gold" is an unapproved new drug under sections 505(a) and 301(d) of the FD&C Act, as sibutramine was authorized for investigation as a new drug before being marketed as a dietary supplement. The product is also a misbranded drug under sections 502 and 301(a) because it lacks adequate directions for use, its labeling is false/misleading by not declaring sibutramine and phenolphthalein, and it lacks adequate warnings, making it dangerous to health.

The letter requires a written response within fifteen working days detailing corrective actions, steps to prevent recurrence, and supporting documentation. Failure to comply may result in legal action, including seizure or injunction. The FDA also noted other products marketed by the firm, emphasizing the firm's responsibility to ensure they do not contain undeclared

Company
genesis nutrition ultra slim
Inspection date
September 7, 2021
Product type
Drugs
Office
Office of Pharmaceutical Quality Operations Division I
Person
  • John W. Diehl (John W. Diehl, M.S.Program Division)
View Company Profile

ID · 6c7e70c2-8154-4261-9149-b5a560e2d34c

Violation Codes10
21 U.S.C. 331(a)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 U.S.C. 321(ff)(3)(B)(ii)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 352(a)21 U.S.C. 321(n)21 U.S.C. 352(f)(2)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore genesis nutrition ultra slim
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.